June 30, 2025
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Sawicki
| Re: | Alpha Tau Medical Ltd. | |
| Registration Statement on Form F-3 | ||
| Filed June 23, 2025 | ||
| File No. 333-288240 |
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on July 2, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Nathan Ajiashvili of Latham & Watkins LLP, counsel to the Company, at +1.212.906.2916, or in his absence, Joshua G. Kiernan at +44.20.7710.5820, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
[Signature Page Follows]
| Sincerely yours, | ||
| Alpha Tau Medical Ltd. | ||
| By: | /s/ Uzi Sofer | |
| Uzi Sofer | ||
| Chief Executive Officer | ||
| cc: | Nathan Ajiashvili, Esq. |
[Signature Page to Acceleration Request]